Ben-Tov, A.; Lebwohl, B.; Banon, T.; Chodick, G.; Kariv, R.; Assa, A.; Gazit, S.; Patalon, T.
BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign. Viruses 2023, 15, 1968.
https://doi.org/10.3390/v15091968
AMA Style
Ben-Tov A, Lebwohl B, Banon T, Chodick G, Kariv R, Assa A, Gazit S, Patalon T.
BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign. Viruses. 2023; 15(9):1968.
https://doi.org/10.3390/v15091968
Chicago/Turabian Style
Ben-Tov, Amir, Benjamin Lebwohl, Tamar Banon, Gabriel Chodick, Revital Kariv, Amit Assa, Sivan Gazit, and Tal Patalon.
2023. "BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign" Viruses 15, no. 9: 1968.
https://doi.org/10.3390/v15091968
APA Style
Ben-Tov, A., Lebwohl, B., Banon, T., Chodick, G., Kariv, R., Assa, A., Gazit, S., & Patalon, T.
(2023). BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign. Viruses, 15(9), 1968.
https://doi.org/10.3390/v15091968